?reatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Metastatic Breast Cancer
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece To evaluate the outcome of patients per treatment line (objective response, progression free survival, time to disease progression per line of therapy), overall survival To rec...
To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece To evaluate the outcome of patients per treatment line (objective response, progression free survival, time to disease progression per line of therapy), overall survival To record adverse events per line of therapy To recording of the causes of treatment discontinuation per line of therapy
Tracking Information
- NCT #
- NCT04247035
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ioannis Boukovinas, Dr /Phd HeSMO
Get Well Soon